ZA200508714B - Modafinil synthesis process - Google Patents
Modafinil synthesis process Download PDFInfo
- Publication number
- ZA200508714B ZA200508714B ZA200508714A ZA200508714A ZA200508714B ZA 200508714 B ZA200508714 B ZA 200508714B ZA 200508714 A ZA200508714 A ZA 200508714A ZA 200508714 A ZA200508714 A ZA 200508714A ZA 200508714 B ZA200508714 B ZA 200508714B
- Authority
- ZA
- South Africa
- Prior art keywords
- process according
- modafinil
- solution
- dmsam
- temperature
- Prior art date
Links
- YFGHCGITMMYXAQ-UHFFFAOYSA-N 2-[(diphenylmethyl)sulfinyl]acetamide Chemical compound C=1C=CC=CC=1C(S(=O)CC(=O)N)C1=CC=CC=C1 YFGHCGITMMYXAQ-UHFFFAOYSA-N 0.000 title claims description 52
- 229960001165 modafinil Drugs 0.000 title claims description 49
- 238000000034 method Methods 0.000 title claims description 44
- 230000015572 biosynthetic process Effects 0.000 title description 8
- 238000003786 synthesis reaction Methods 0.000 title description 3
- 239000002245 particle Substances 0.000 claims description 31
- 238000003756 stirring Methods 0.000 claims description 19
- 238000001033 granulometry Methods 0.000 claims description 17
- 239000002904 solvent Substances 0.000 claims description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 238000002425 crystallisation Methods 0.000 claims description 3
- 230000008025 crystallization Effects 0.000 claims description 3
- 239000003586 protic polar solvent Substances 0.000 claims description 3
- 238000001953 recrystallisation Methods 0.000 claims description 3
- 230000009466 transformation Effects 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- 125000003158 alcohol group Chemical group 0.000 claims 1
- 238000004090 dissolution Methods 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 12
- 238000009826 distribution Methods 0.000 description 10
- 239000000243 solution Substances 0.000 description 8
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- 229910021529 ammonia Inorganic materials 0.000 description 6
- 239000000543 intermediate Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 3
- GYXHHICIFZSKKZ-UHFFFAOYSA-N 2-sulfanylacetamide Chemical compound NC(=O)CS GYXHHICIFZSKKZ-UHFFFAOYSA-N 0.000 description 2
- XKJMBINCVNINCA-UHFFFAOYSA-N Alfalone Chemical compound CON(C)C(=O)NC1=CC=C(Cl)C(Cl)=C1 XKJMBINCVNINCA-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- KPSSIOMAKSHJJG-UHFFFAOYSA-N neopentyl alcohol Chemical compound CC(C)(C)CO KPSSIOMAKSHJJG-UHFFFAOYSA-N 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 125000001174 sulfone group Chemical group 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 1
- BIASHYVHAQBNGV-UHFFFAOYSA-N 3,3-diphenylpropanethioic s-acid Chemical compound C=1C=CC=CC=1C(CC(=S)O)C1=CC=CC=C1 BIASHYVHAQBNGV-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000003869 acetamides Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000002902 bimodal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 1
- 230000009021 linear effect Effects 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 201000003631 narcolepsy Diseases 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- -1 pentarucl Chemical compound 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000003444 phase transfer catalyst Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000004763 sulfides Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C315/00—Preparation of sulfones; Preparation of sulfoxides
- C07C315/04—Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C315/00—Preparation of sulfones; Preparation of sulfoxides
- C07C315/06—Separation; Purification; Stabilisation; Use of additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C07C317/48—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C317/50—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03291152A EP1477476B1 (en) | 2003-05-16 | 2003-05-16 | Modafinil synthesis process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200508714B true ZA200508714B (en) | 2006-07-26 |
Family
ID=33017031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200508714A ZA200508714B (en) | 2003-05-16 | 2005-10-27 | Modafinil synthesis process |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7541493B2 (es) |
| EP (1) | EP1477476B1 (es) |
| JP (1) | JP4825673B2 (es) |
| KR (1) | KR101054262B1 (es) |
| CN (1) | CN100400507C (es) |
| AR (1) | AR044329A1 (es) |
| AT (1) | ATE442352T1 (es) |
| AU (1) | AU2004238636B2 (es) |
| CA (1) | CA2525317C (es) |
| CL (1) | CL2004001052A1 (es) |
| DE (1) | DE60329167D1 (es) |
| ES (1) | ES2330321T3 (es) |
| HK (1) | HK1071125A1 (es) |
| IL (1) | IL171588A (es) |
| MX (1) | MXPA05012213A (es) |
| NZ (1) | NZ543237A (es) |
| TW (1) | TWI334861B (es) |
| WO (1) | WO2004101503A1 (es) |
| ZA (1) | ZA200508714B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20020032023A (ko) * | 2000-10-25 | 2002-05-03 | 이성식 | 저공해 환경 연료 |
| US6992219B2 (en) | 2002-08-09 | 2006-01-31 | Cephalon France | Modafinil polymorphic forms |
| US7368591B2 (en) | 2003-09-19 | 2008-05-06 | Cephalon France | Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation |
| EP1702915A1 (en) | 2005-03-14 | 2006-09-20 | Cephalon France | Process for enantioselective synthesis of single enantiomers of thio-substituted arylmethanesulfinyl derivatives by asymmetric oxidation |
| US7960586B2 (en) * | 2007-08-16 | 2011-06-14 | Teva Pharmaceutical Industries Ltd. | Purification of armodafinil |
| BR112012023892B1 (pt) * | 2010-03-16 | 2018-12-11 | Mitsubishi Chemical Corporation | processo para produzir ácido succínico |
| CN103412062A (zh) * | 2013-07-17 | 2013-11-27 | 张家港威胜生物医药有限公司 | 一种测定莫达非尼含量的高效液相色谱法 |
| US9616068B2 (en) | 2014-10-27 | 2017-04-11 | Pohela LLC | Animal training using cognitive enhancement |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1584462A (en) * | 1977-03-31 | 1981-02-11 | Lafon Labor | N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them |
| US4476248A (en) * | 1983-02-28 | 1984-10-09 | The Upjohn Company | Crystallization of ibuprofen |
| FR2593809B1 (fr) * | 1986-01-31 | 1988-07-22 | Lafon Labor | Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique |
| FR2707637B1 (fr) * | 1993-06-30 | 1995-10-06 | Lafon Labor | Nouveaux dérivés d'acétamide, leur procédé de préparation et leur utilisation en thérapeutique. |
| US5618845A (en) * | 1994-10-06 | 1997-04-08 | Cephalon, Inc. | Acetamide derivative having defined particle size |
| JP2002020379A (ja) * | 2000-05-02 | 2002-01-23 | Sumika Fine Chemicals Co Ltd | シタロプラム臭化水素酸塩の結晶およびその結晶化方法 |
| DE10034802A1 (de) * | 2000-07-18 | 2002-01-31 | Bayer Ag | Stabile Salze von O-Acetylsalicylsäure mit basischen Aminosäuren |
| AU2001283008A1 (en) * | 2000-07-27 | 2002-02-13 | Teva Pharmaceutical Industries Ltd. | Crystalline and pure modafinil, and process of preparing the same |
| US6992219B2 (en) | 2002-08-09 | 2006-01-31 | Cephalon France | Modafinil polymorphic forms |
| JP3838972B2 (ja) * | 2002-12-25 | 2006-10-25 | Ｎｅｃエレクトロニクス株式会社 | 周波数検出回路及びデータ処理装置 |
-
2003
- 2003-05-16 ES ES03291152T patent/ES2330321T3/es not_active Expired - Lifetime
- 2003-05-16 DE DE60329167T patent/DE60329167D1/de not_active Expired - Lifetime
- 2003-05-16 EP EP03291152A patent/EP1477476B1/en not_active Expired - Lifetime
- 2003-05-16 AT AT03291152T patent/ATE442352T1/de not_active IP Right Cessation
-
2004
- 2004-05-05 KR KR1020057020878A patent/KR101054262B1/ko not_active IP Right Cessation
- 2004-05-05 AU AU2004238636A patent/AU2004238636B2/en not_active Ceased
- 2004-05-05 JP JP2006530629A patent/JP4825673B2/ja not_active Expired - Fee Related
- 2004-05-05 WO PCT/IB2004/001409 patent/WO2004101503A1/en active Application Filing
- 2004-05-05 US US10/557,072 patent/US7541493B2/en not_active Expired - Fee Related
- 2004-05-05 NZ NZ543237A patent/NZ543237A/en unknown
- 2004-05-05 CN CNB2004800133703A patent/CN100400507C/zh not_active Expired - Fee Related
- 2004-05-05 CA CA2525317A patent/CA2525317C/en not_active Expired - Fee Related
- 2004-05-05 MX MXPA05012213A patent/MXPA05012213A/es active IP Right Grant
- 2004-05-11 TW TW093113198A patent/TWI334861B/zh not_active IP Right Cessation
- 2004-05-14 AR ARP040101640A patent/AR044329A1/es not_active Application Discontinuation
- 2004-05-14 CL CL200401052A patent/CL2004001052A1/es unknown
-
2005
- 2005-05-06 HK HK05103847.4A patent/HK1071125A1/xx not_active IP Right Cessation
- 2005-10-27 IL IL171588A patent/IL171588A/en not_active IP Right Cessation
- 2005-10-27 ZA ZA200508714A patent/ZA200508714B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE442352T1 (de) | 2009-09-15 |
| CN1791571A (zh) | 2006-06-21 |
| JP4825673B2 (ja) | 2011-11-30 |
| HK1071125A1 (en) | 2005-07-08 |
| NZ543237A (en) | 2009-04-30 |
| EP1477476A1 (en) | 2004-11-17 |
| ES2330321T3 (es) | 2009-12-09 |
| AR044329A1 (es) | 2005-09-07 |
| MXPA05012213A (es) | 2006-02-08 |
| US7541493B2 (en) | 2009-06-02 |
| IL171588A (en) | 2011-02-28 |
| CA2525317C (en) | 2012-07-10 |
| WO2004101503A1 (en) | 2004-11-25 |
| CN100400507C (zh) | 2008-07-09 |
| AU2004238636B2 (en) | 2010-12-16 |
| EP1477476A8 (en) | 2005-06-22 |
| JP2006528966A (ja) | 2006-12-28 |
| EP1477476B1 (en) | 2009-09-09 |
| CL2004001052A1 (es) | 2005-01-28 |
| KR101054262B1 (ko) | 2011-08-08 |
| CA2525317A1 (en) | 2004-11-25 |
| US20070015836A1 (en) | 2007-01-18 |
| KR20060017600A (ko) | 2006-02-24 |
| TW200510287A (en) | 2005-03-16 |
| DE60329167D1 (de) | 2009-10-22 |
| AU2004238636A1 (en) | 2004-11-25 |
| TWI334861B (en) | 2010-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200508714B (en) | Modafinil synthesis process | |
| CN107382820B (zh) | 一种3-芳基异吲哚衍生物的合成方法 | |
| CA2045107C (en) | Process for preparing organic esters and amides and catalyst system therefor | |
| CN111333543B (zh) | 一种利匹韦林中间体的合成方法 | |
| AU2016426847B2 (en) | Method for preparing deuterated imidazole diketone compound | |
| CN112159359A (zh) | 一种尿嘧啶的绿色制备方法 | |
| CN112624957A (zh) | 一种3-烷基异吲哚啉酮类衍生物的合成方法 | |
| NO327178B1 (no) | Fremgangsmate for fremstilling av 3,4-metylendioksy-mandelsyre | |
| JP2018135293A (ja) | アミド化合物の製造方法 | |
| JPS6121475B2 (es) | ||
| JP2018519288A (ja) | ベンズアミド化合物の製造方法 | |
| CN111138299A (zh) | 一种三芳基甲烷类化合物的无溶剂绿色合成方法 | |
| CN108299206B (zh) | 一种1-亚硝基-2-萘酚的纯化方法 | |
| EP2649044B1 (en) | Method for synthesising substituted aminocyclohexanone derivatives | |
| CN114149353B (zh) | 一类n-烷基/n-芳基硫代酰胺衍生物及其合成方法和应用 | |
| CN113387792A (zh) | 一种洛索洛芬钠工艺杂质的合成方法 | |
| JP2007261982A (ja) | キナゾリン−２，４−ジオン誘導体の製造方法 | |
| WO2004018408A1 (en) | Synthesis and purification of nateglinide | |
| JP4807675B2 (ja) | 高純度ピペラジン誘導体塩酸塩の製造方法 | |
| EP3415491B1 (en) | Method for producing phenoxyethanol derivative | |
| CN116715635A (zh) | 5-正丙基海因的合成工艺 | |
| KR19990025231A (ko) | 2-(2,6-디클로로페닐)아미노)페닐아세톡시아세트산의제조방법 | |
| JP4340914B2 (ja) | 新規な２，４，６−トリメルカプト−１，３，５−トリアジンのトリリチウム塩又はトリカリウム塩の水和物並びに水和物及び無水物の製造法 | |
| WO1984000543A1 (en) | Single crystalline dl-cysteine and process for their preparation | |
| MX2010011835A (es) | Proceso para la produccion de compuesto que tiene actividad antagonista al receptor de npyy5 y cristal util. |